Login / Signup

Prevalence and impact of chronic dysglycaemia among patients with COVID-19 in Swedish intensive care units: a multicentre, retrospective cohort study.

Anca BalintescuSusanne RyszCarl HertzJonathan GripMaria CronhjortAnders OldnerChrister SvensenJohan Mårtensson
Published in: BMJ open (2023)
In our cohort of critically ill COVID-19 patients, the prevalence of chronic dysglycaemia was 82%. We found no robust associations between chronic dysglycaemia and clinical outcomes when accounting for treatment limitations.
Keyphrases
  • intensive care unit
  • risk factors
  • clinical trial
  • randomized controlled trial